ID
37149
Description
Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02404558
Lien
https://clinicaltrials.gov/show/NCT02404558
Mots-clés
Versions (1)
- 04/07/2019 04/07/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
4 juillet 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Rheumatoid Arthritis NCT02404558
Eligibility Rheumatoid Arthritis NCT02404558
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Age
Type de données
boolean
Alias
- UMLS CUI [1]
- C0001779
Description
Interleukin-6 Antagonist | Interleukin-6 Receptor Antagonist
Type de données
boolean
Alias
- UMLS CUI [1]
- C3864917
- UMLS CUI [2]
- C3819026
Description
Glucocorticoid Parenteral Injection | Glucocorticoid Intra-Articular Injection
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0017710
- UMLS CUI [1,2]
- C1555373
- UMLS CUI [2,1]
- C0017710
- UMLS CUI [2,2]
- C0021488
Description
Prednisone U/day | Equivalent U/day | Prednisone Dosage Change
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0032952
- UMLS CUI [1,2]
- C0456683
- UMLS CUI [2,1]
- C0205163
- UMLS CUI [2,2]
- C0456683
- UMLS CUI [3,1]
- C0032952
- UMLS CUI [3,2]
- C0178602
- UMLS CUI [3,3]
- C0392747
Description
DMARDs | Immunosuppressive Agents | TNF-inhibitors | Biological agents Targeting Rheumatoid Arthritis
Type de données
boolean
Alias
- UMLS CUI [1]
- C0242708
- UMLS CUI [2]
- C0021081
- UMLS CUI [3]
- C3653350
- UMLS CUI [4,1]
- C0005515
- UMLS CUI [4,2]
- C1521840
- UMLS CUI [4,3]
- C0003873
Description
Study Subject Participation Status | Investigational New Drugs | Therapies, Investigational
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
- UMLS CUI [2]
- C0013230
- UMLS CUI [3]
- C0949266
Description
Tuberculosis | Tuberculosis Suspected | High risk of Tuberculosis
Type de données
boolean
Alias
- UMLS CUI [1]
- C0041296
- UMLS CUI [2,1]
- C0041296
- UMLS CUI [2,2]
- C0750491
- UMLS CUI [3,1]
- C0332167
- UMLS CUI [3,2]
- C0041296
Description
Fever Treatment required for | Chronic infectious disease Treatment required for | Persistent infection Treatment required for | Recurrent infections Treatment required for
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0015967
- UMLS CUI [1,2]
- C0332121
- UMLS CUI [2,1]
- C0151317
- UMLS CUI [2,2]
- C0332121
- UMLS CUI [3,1]
- C1264606
- UMLS CUI [3,2]
- C0332121
- UMLS CUI [4,1]
- C0239998
- UMLS CUI [4,2]
- C0332121
Description
Study Subject Participation Status Consideration Additional
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C0518609
- UMLS CUI [1,3]
- C1524062
Similar models
Eligibility Rheumatoid Arthritis NCT02404558
- StudyEvent: Eligibility
C0008902 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C3819026 (UMLS CUI [2])
C1555373 (UMLS CUI [1,2])
C0017710 (UMLS CUI [2,1])
C0021488 (UMLS CUI [2,2])
C0456683 (UMLS CUI [1,2])
C0205163 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0032952 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0392747 (UMLS CUI [3,3])
C0021081 (UMLS CUI [2])
C3653350 (UMLS CUI [3])
C0005515 (UMLS CUI [4,1])
C1521840 (UMLS CUI [4,2])
C0003873 (UMLS CUI [4,3])
C0013230 (UMLS CUI [2])
C0949266 (UMLS CUI [3])
C0041296 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0332167 (UMLS CUI [3,1])
C0041296 (UMLS CUI [3,2])
C0332121 (UMLS CUI [1,2])
C0151317 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
C1264606 (UMLS CUI [3,1])
C0332121 (UMLS CUI [3,2])
C0239998 (UMLS CUI [4,1])
C0332121 (UMLS CUI [4,2])
C0518609 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])